sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> vaccine adjuvants market

report

Vaccine Adjuvants Market, by Type (Pathogen, Adjuvant Emulsion, Particulate, Combination, Others), Application (Infectious Disease, Cancer, Others), Administration Type (Oral, Intradermal, Intranasal, Intramuscular, Others) – Global Revenue, Trends, Growth, Share, Size, and Forecast to 2022

HC421 October 2017 100+ FREE 10% CUSTOMIZATION

Compounds called adjuvants enhance the body’s immunogenic response against antigens. Hence, adjuvants area unit another to vaccines to extend their ability to induce semi-permanent protection against infections. Vaccines adjuvants area unit within the method of development, and presently metal salts and MF59 area unit the sole adjuvants found possible for human use. R&D for potent vaccines adjuvants is progressing at a forceful rate when the event of new-generation vaccines. modern vaccines area unit less immunogenic, so leading to the requirement for a lot of powerful adjuvants to be used in vaccines. This needs to crystal rectifier to high investments by researchers and scientists to take a position in R&D activities for safer and effective vaccinum adjuvants, so enhancing market growth.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the vaccine adjuvants market. The scope of this report covers the vaccine adjuvants market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Factors driving the global vaccines adjuvants market area unit rising support of presidency in R&D, high prevalence of diseases, increasing specialise in improved vaccines, and strategic biological process moves adopted by firms like agreements, acquisitions, and collaborations. However, facet effects of adjuvants and price of adjuvant development prohibit the market growth.
  • Moreover, rising markets area unit gap avenues of opportunities for the expansion of this market. The demand for this market can increase as adjuvants are required to reinforce and extend immune responses whereas reducing the number of substance necessary in every dose. The restricted immunogenicity of latest and novel vaccines antigens has augmented the importance of adjuvant analysis in vaccinum development.
  • There's a desire for development of safe and non-toxic adjuvants. Vaccines containing novel adjuvant formulations area unit more and more reaching advanced development and licensing stages, providing new tools to fill antecedently unmet clinical wants. However, several adjuvants fail throughout development attributable to factors like manufacturability, stability, lack of effectiveness, unacceptable levels of tolerability or safety issues.

Regionally, the global vaccine adjuvants market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, North America command the most important market share in 2016 followed by Europe. The factors conducive to growth of vaccinum adjuvants market within the North yank region area unit rise in investments for R&D of latest medical specialty and increase in fatal epidemic diseases. Thus, resulting in the requirement for protection against acute and chronic diseases. additionally, native presence of key market players within the U.S. will increase the penetration of merchandise. Asia Pacific was calculable to be the quickest growing market owing to the incessantly rising aid facilities, as well as handiness of medicines, let alone rising R&D funding to fulfill the massive unmet demands. this can be expected to extend the revenue share over the forecast amount.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s vaccine adjuvants market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the vaccine adjuvants market by the following segments:

  • Vaccine Adjuvants Market, by Product Type
    • Pathogen
    • Adjuvant Emulsion
    • Particulate
    • Combination
    • Others
  • Vaccine Adjuvants Market, by Application
    • Infectious Disease
    • Cancer
    • Others
  • Vaccine Adjuvants Market, by Administration Type
    • Oral
    • Intradermal
    • Intranasal
    • Intramuscular
    • Others

KEY MARKET PLAYERS

Key players in the vaccine adjuvants market include:

  • GSK
  • Novartis/CSL
  • Agenus
  • Adjuvance
  • Novavax
  • SPI Pharma
  • Invivogen
  • Brentagg

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Orphan Drugs Market, by Type (Biological Orphan Drugs, Non-Biological Orphan Drugs), Therapeutic Area (Oncology, Neurology, Hematology, Infectious Disease, Metabolic Disease, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
  5. VACCINE ADJUVANTS MARKET, BY PRODUCT TYPE
    1. Segment Share
    2. By Product Type
      1. Pathogen
      2. Adjuvant Emulsion
      3. Particulate
      4. Combination
      5. Others
  6. VACCINE ADJUVANTS MARKET, BY APPLICATION
    1. Segment Share
    2. By Application
      1. Infectious Disease
      2. Cancer
      3. Others
  7. VACCINE ADJUVANTS MARKET, BY ADMINISTRATION TYPE
    1. Segment Share
    2. By Administration Type
      1. Oral
      2. Intradermal
      3. Intranasal
      4. Intramuscular
      5. Others
  8. VACCINE ADJUVANTS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Product Type
      3. By Application
      4. By Administration Type
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Product Type
      3. By Application
      4. By Administration Type
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Product Type
      3. By Application
      4. By Administration Type
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Product Type
      3. By Application
      4. By Administration Type
  9. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. GSK
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Novartis/CSL
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Agenus
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Adjuvance
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Novavax
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. SPI Pharma
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Invivogen
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Brentagg
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us